Alcon
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alcon and other ETFs, options, and stocks.About ALC
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments.
ALC Key Statistics
ALC News
Needham analyst David Saxon reiterated a Buy rating on Alcon on August 20 and set a price target of $107.00. Elevate Your Investing Strategy: Take advantage of...
Healthcare Alcon downgraded at J.P. Morgan on Q2 results Aug. 21, 2025 10:42 AM ET Alcon Inc. (ALC) Stock By: Dulan Lokuwithana, SA News Editor 5 Share Save (...
Alcon Inc ALC posted better-than-expected earnings for the second quarter and cut its 2025 outlook late on Tuesday, citing increased tariff impact. The company...
Analyst ratings
74%
of 31 ratingsMore ALC News
Morgan Stanley analyst Patrick Wood lowered the firm’s price target on Alcon (ALC) to $80 from $84 and keeps an Equal Weight rating on the shares after updating...
Earnings Call Insights Alcon updates 2025 revenue outlook to $10.3B–$10.4B while advancing strategic acquisitions and new product launches Aug. 20, 2025 9:11 PM...
Swiss-American eye care firm Alcon Inc ALC stock slumped on Wednesday after the company cut its 2025 outlook late on Tuesday, citing increased tariff impact. T...
Julien Ouaddour, an analyst from Bank of America Securities, maintained the Buy rating on Alcon. The associated price target remains the same with CHF89.00. Ele...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Reports Q2 revenue $2.58B, consensus $2.64B. “Alcon (ALC) is exiting the second quarter with solid momentum, despite a relatively soft surgical market in the fi...